Trading a HRMY straddle lets you take a pure volatility position on Harmony Biosciences Holdings Inc without committing to a direction. Harmony Biosciences Holdings Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate HRMY straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on HRMY profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Harmony Biosciences Holdings Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the HRMY straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the HRMY straddle is the cleanest expression of that view. Our scanner prices every HRMY straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a HRMY straddle into a catalyst or short a HRMY straddle to harvest decay, the options straddle setups that matter are all in one place.
